Cargando…
Colorectal cancer screening: will non-invasive procedures triumph?
In the US, colorectal cancer is the fourth most common cancer and the second most deadly. Screening is recommended, not only to reduce mortality, but to prevent cancer by detecting precancerous polyps. Many screening methods are available now, and newer methods based on molecular markers show promis...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062046/ https://www.ncbi.nlm.nih.gov/pubmed/25031625 http://dx.doi.org/10.1186/gm562 |
_version_ | 1782321583604367360 |
---|---|
author | Church, Timothy |
author_facet | Church, Timothy |
author_sort | Church, Timothy |
collection | PubMed |
description | In the US, colorectal cancer is the fourth most common cancer and the second most deadly. Screening is recommended, not only to reduce mortality, but to prevent cancer by detecting precancerous polyps. Many screening methods are available now, and newer methods based on molecular markers show promise for the future. |
format | Online Article Text |
id | pubmed-4062046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40620462015-06-10 Colorectal cancer screening: will non-invasive procedures triumph? Church, Timothy Genome Med Q and A In the US, colorectal cancer is the fourth most common cancer and the second most deadly. Screening is recommended, not only to reduce mortality, but to prevent cancer by detecting precancerous polyps. Many screening methods are available now, and newer methods based on molecular markers show promise for the future. BioMed Central 2014-06-10 /pmc/articles/PMC4062046/ /pubmed/25031625 http://dx.doi.org/10.1186/gm562 Text en Copyright © 2014 Church; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Q and A Church, Timothy Colorectal cancer screening: will non-invasive procedures triumph? |
title | Colorectal cancer screening: will non-invasive procedures triumph? |
title_full | Colorectal cancer screening: will non-invasive procedures triumph? |
title_fullStr | Colorectal cancer screening: will non-invasive procedures triumph? |
title_full_unstemmed | Colorectal cancer screening: will non-invasive procedures triumph? |
title_short | Colorectal cancer screening: will non-invasive procedures triumph? |
title_sort | colorectal cancer screening: will non-invasive procedures triumph? |
topic | Q and A |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062046/ https://www.ncbi.nlm.nih.gov/pubmed/25031625 http://dx.doi.org/10.1186/gm562 |
work_keys_str_mv | AT churchtimothy colorectalcancerscreeningwillnoninvasiveprocedurestriumph |